ISPOR, the professional society for health economics and outcomes research, announced today the publication of new recommendations for economic analysis of vaccination programs given limited resources and budgets. The recommendations, issued by the ISPOR Economic Evaluation of Vaccines Designed to Prevent Infectious Disease: Good Practices Task Force, are applicable to countries of various income levels. The report, Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report: An ISPOR Good Practices for Outcomes Research Task Force Report, was published in the October 2018 issue of Value in Health.
The Task Force report provides good practice recommendations for three specific analysis methods-cost-effectiveness analysis, constrained optimization modeling, and fiscal health modeling-to assess the economic impact of vaccination and comparator programs to inform decision makers and budget holders. These 3 approaches are useful to decision makers with different policy objectives working in different decision contexts and the recommendations are applicable to high-, middle-, and low-income countries. These complementary methodological approaches can offer an integrated economic perspective of a new vaccination program’s value in a useful format for meeting policy objectives based on the best available evidence.
The report presents 14 categories of best-practice recommendations and explanatory information for cost-effectiveness analysis, constrained optimization modeling, and fiscal health modeling. The recommendations are grouped into 4 main topics:
Decision description (policy objective, decision context and perspective)
Disease modeling approaches (model structure, time horizon, comparators, data requirements and sources, outcome measures)
Data evaluation (analysis method and interpretation, discount rates, uncertainty analysis, validation)
Logistics (software, transparency, reporting)
“Our recommendations take a global perspective where the decision maker, along with the policy objective and decision context, determine which method(s) to use and how to operationalize each method and identify the input data needed,” said task force co-chair Josephine Mauskopf, PhD, vice president of health economics, RTI Health Solutions. “This report does not propose normative rules that identify desirable policy objectives or recommend specific methods to achieve each policy objective. However, decision makers in different decision contexts can use the best practices for the analyses described in this report to make sound decisions about a vaccination program.”
Source: ISPOR-The Professional Society for Health Economics and Outcomes Research
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.